Stocks / SHC / P/E Ratio

Sotera Health Company P/E Ratio 2019–2025

Sotera Health Company reported 65.33 of price-to-earnings ratio for fiscal 2025. That was 23.6% lower than fiscal 2024. Compared with fiscal 2021, the change was +13.7%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.

Latest filed value
65.33
One-year change
-23.6%
Change since 2021
+13.7%
Latest period end
2025-12-31
Sotera Health Company P/E Ratio history from 2021 to 2025FY 2021: 57.43902252941597FY 2023: 93.61111323038737FY 2024: 85.50000190734863FY 2025: 65.33333107277198
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearP/E RatioChange (YoY)
FY 202565.33-23.6%
FY 202485.50-8.7%
FY 202393.61
FY 2022
FY 202157.44
FY 2020
FY 2019

Source: Sotera Health Company SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open SHC 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

Sotera Health Company reported 65.33 of price-to-earnings ratio for fiscal 2025. That was 23.6% lower than fiscal 2024. Compared with fiscal 2021, the change was +13.7%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for Sotera Health Company

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Sotera Health Company — frequently asked questions

What is Sotera Health Company's price-to-earnings ratio?

Sotera Health Company (SHC) reported price-to-earnings ratio of 65.33 for fiscal year 2025, per its SEC filings.

How has Sotera Health Company's price-to-earnings ratio changed over time?

Between fiscal 2019 and 2025, SHC's price-to-earnings ratio grew at roughly 2.2% per year (compound annual rate), from 57.44 to 65.33.

Where does this data come from?

Figures are computed from Sotera Health Company's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.

More SHC financial history

Full SHC fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →